{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:13Z","timestamp":1792787893812,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Clinical Technology Foundation of Jiangsu Province","award":["BL2012042"],"award-info":[{"award-number":["BL2012042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12872-018-0987-x","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T07:39:10Z","timestamp":1546673950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Circulating microRNA-1 in the diagnosis and predicting prognosis of patients with chest pain: a prospective cohort study"],"prefix":"10.1186","volume":"19","author":[{"given":"Tong","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-1864","authenticated-orcid":false,"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"issue":"3","key":"987_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4065\/mcp.2009.0560","volume":"85","author":"MC Kontos","year":"2010","unstructured":"Kontos MC, Diercks DB, Kirk JD. Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc. 2010;85(3):284\u201399.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"987_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, et al. 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the Management of Acute Coronary Syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37(3):267\u2013315.","journal-title":"Eur Heart J"},{"issue":"25","key":"987_CR3","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","volume":"130","author":"EA Amsterdam","year":"2014","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;130(25):2354\u201394.","journal-title":"Circulation"},{"issue":"22","key":"987_CR4","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","volume":"116","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, et al. Universal definition of myocardial infarction. Circulation. 2007;116(22):2634\u201353.","journal-title":"Circulation"},{"issue":"3","key":"987_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1185\/030079906X167462","volume":"23","author":"MJ Taylor","year":"2007","unstructured":"Taylor MJ, Scuffham PA, McCollam PL, Newby DE. Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr Med Res Opin. 2007;23(3):495\u2013503.","journal-title":"Curr Med Res Opin"},{"issue":"1 Suppl","key":"987_CR6","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1002\/hec.1322","volume":"17","author":"O Tiemann","year":"2008","unstructured":"Tiemann O. Variations in hospitalisation costs for acute myocardial infarction - a comparison across Europe. Health Econ. 2008;17(1 Suppl):S33\u201345.","journal-title":"Health Econ"},{"issue":"6","key":"987_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/hrt.2010.205617","volume":"97","author":"JO Baker","year":"2011","unstructured":"Baker JO, Reinhold J, Redwood S, Marber MS. Troponins: redefining their limits. Heart. 2011;97(6):447\u201352.","journal-title":"Heart"},{"issue":"4","key":"987_CR8","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/eurheartj\/ehq456","volume":"32","author":"S Agewall","year":"2011","unstructured":"Agewall S, Giannitsis E, Jernberg T, Katus H. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J. 2011;32(4):404\u201311.","journal-title":"Eur Heart J"},{"key":"987_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1741-7015-8-34","volume":"8","author":"D Chan","year":"2010","unstructured":"Chan D, Ng LL. Biomarkers in acute myocardial infarction. BMC Med. 2010;8:34.","journal-title":"BMC Med"},{"issue":"7006","key":"987_CR10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature02873","volume":"431","author":"G Meister","year":"2004","unstructured":"Meister G, Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature. 2004;431(7006):343\u20139.","journal-title":"Nature"},{"issue":"21","key":"987_CR11","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1242\/dev.02073","volume":"132","author":"I Alvarez-Garcia","year":"2005","unstructured":"Alvarez-Garcia I, Miska EA. MicroRNA functions in animal development and human disease. Development (Cambridge England). 2005;132(21):4653\u201362.","journal-title":"Development (Cambridge England)"},{"issue":"7","key":"987_CR12","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00109-008-0341-3","volume":"86","author":"Z Wang","year":"2008","unstructured":"Wang Z, Luo X, Lu Y, Yang B. miRNAs at the heart of the matter. J Mol Med (Berl). 2008;86(7):771\u201383.","journal-title":"J Mol Med (Berl)"},{"key":"987_CR13","doi-asserted-by":"crossref","unstructured":"Condorelli G, Latronico MV, Dorn GW, 2nd. microRNAs in heart disease: putative novel therapeutic targets? Eur Heart J 2010;31(6):649\u2013658.","DOI":"10.1093\/eurheartj\/ehp573"},{"key":"987_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","volume":"12","author":"M Lagos-Quintana","year":"2002","unstructured":"Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr Biol. 2002;12:735\u20139.","journal-title":"Curr Biol"},{"issue":"7048","key":"987_CR15","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature03817","volume":"436","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436(7048):214\u201320.","journal-title":"Nature"},{"issue":"2","key":"987_CR16","doi-asserted-by":"publisher","first-page":"e000078","DOI":"10.1161\/JAHA.113.000078","volume":"2","author":"I Karakikes","year":"2013","unstructured":"Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, et al. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc. 2013;2(2):e000078.","journal-title":"J Am Heart Assoc"},{"key":"987_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcard.2017.06.054","volume":"244","author":"U Grabmaier","year":"2017","unstructured":"Grabmaier U, Clauss S, Gross L, Klier I, Franz WM, Steinbeck G, et al. Diagnostic and prognostic value of miR-1 and miR-29b on adverse ventricular remodeling after acute myocardial infarction - the SITAGRAMI-miR analysis. Int J Cardiol. 2017;244:30\u20136.","journal-title":"Int J Cardiol"},{"issue":"18","key":"987_CR18","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/eurheartj\/ehq251","volume":"31","author":"K Thygesen","year":"2010","unstructured":"Thygesen K, Mair J, Katus H, Plebani M, Venge P, Collinson P, et al. Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010;31(18):2197\u2013204.","journal-title":"Eur Heart J"},{"issue":"13","key":"987_CR19","first-page":"e352","volume":"115","author":"FS Apple","year":"2007","unstructured":"Apple FS, Jesse RL, Newby LK, Wu AH, Christenson RH. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation. 2007;115(13):e352\u20135.","journal-title":"Circulation"},{"issue":"18","key":"987_CR20","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1093\/eurheartj\/ehs154","volume":"33","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Mair J, Giannitsis E, Mueller C, Lindahl B, Blankenberg S, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J. 2012;33(18):2252\u20137.","journal-title":"Eur Heart J"},{"issue":"6","key":"987_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.7150\/ijbs.4439","volume":"8","author":"G Long","year":"2012","unstructured":"Long G, Wang F, Duan Q, Chen F, Yang S, Gong W, et al. Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. Int J Biol Sci. 2012;8(6):811\u20138.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"987_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta C (T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"3","key":"987_CR23","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"11","key":"987_CR24","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/emmm.201201749","volume":"4","author":"MI Oerlemans","year":"2012","unstructured":"Oerlemans MI, Mosterd A, Dekker MS, de Vrey EA, van Mil A, Pasterkamp G, et al. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO molecular medicine. 2012;4(11):1176\u201385.","journal-title":"EMBO molecular medicine"},{"issue":"2","key":"987_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/CS20090645","volume":"119","author":"Y Cheng","year":"2010","unstructured":"Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clinical science (LondonEngland: 1979). 2010;119(2):87\u201395.","journal-title":"Clinical science (LondonEngland: 1979)"},{"issue":"1","key":"987_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bbrc.2009.11.005","volume":"391","author":"J Ai","year":"2010","unstructured":"Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010;391(1):73\u20137.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"987_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.114.015134","volume":"132","author":"T Shibata","year":"2015","unstructured":"Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T, et al. Prevalence, clinical features, and prognosis of acute myocardial infarction attributable to coronary artery embolism. Circulation. 2015;132(4):241\u201350.","journal-title":"Circulation"},{"issue":"2","key":"987_CR28","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/joim.12183","volume":"277","author":"Y Devaux","year":"2015","unstructured":"Devaux Y, Mueller M, Haaf P, Goretti E, Twerenbold R, Zangrando J, et al. Diagnostic and prognostic value of circulating microRNAs in patients with acute chest pain. J Intern Med. 2015;277(2):260\u201371.","journal-title":"J Intern Med"},{"issue":"5","key":"987_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.yjmcc.2011.07.011","volume":"51","author":"C Widera","year":"2011","unstructured":"Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol. 2011;51(5):872\u20135.","journal-title":"J Mol Cell Cardiol"},{"key":"987_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3389\/fphys.2018.00664","volume":"9","author":"T Sun","year":"2018","unstructured":"Sun T, Zhang L, Li X, Chen F, Li Y, Ma X, et al. MicroRNA-1 and circulating microvesicles mediate the protective effects of Dantonic in acute myocardial infarction rat models. Front Physiol. 2018;9:664.","journal-title":"Front Physiol"},{"issue":"3","key":"987_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/cvr\/cvs196","volume":"95","author":"J Ai","year":"2012","unstructured":"Ai J, Zhang R, Gao X, Niu HF, Wang N, Xu Y, et al. Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly. Cardiovasc Res. 2012;95(3):385\u201393.","journal-title":"Cardiovasc Res"},{"key":"987_CR32","doi-asserted-by":"publisher","unstructured":"Qipshidze Kelm N, Piell KM, Wang E, Cole MP. MicroRNAs as predictive biomarkers for myocardial injury in aged mice following myocardial infarction. J Cell Physiol. 2017. \n                    https:\/\/doi.org\/10.1002\/jcp.26283\n                    \n                  .","DOI":"10.1002\/jcp.26283"},{"key":"987_CR33","first-page":"428371","volume":"2014","author":"C Han","year":"2014","unstructured":"Han C, Yu Z, Duan Z, Kan Q. Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int. 2014;2014:428371.","journal-title":"Biomed Res Int"},{"issue":"4","key":"987_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2215\/CJN.10471011","volume":"7","author":"C Emilian","year":"2012","unstructured":"Emilian C, Goretti E, Prospert F, Pouthier D, Duhoux P, Gilson G, et al. MicroRNAs in patients on chronic hemodialysis (MINOS study). Clin J Am Soc Nephrol. 2012;7(4):619\u201323.","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-018-0987-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-018-0987-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,4]],"date-time":"2020-01-04T19:08:00Z","timestamp":1578164880000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-018-0987-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["987"],"URL":"https:\/\/doi.org\/10.1186\/s12872-018-0987-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study complies with the Declaration of Helsinki, and Third Affiliated Hospital of Soochow University Research Ethics Committee approved the research protocol. Informed consent was obtained from all individual participants included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflicts of interest. The authors alone are responsible for the content and writing of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"5"}}